Rigel Pharmaceuticals RIGL
$ 27.28
9.32%
Quarterly report 2024-Q3
added 11-07-2024
Rigel Pharmaceuticals Cash Flow 2011-2024 | RIGL
Annual Cash Flow Rigel Pharmaceuticals
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-5.74 M | -73.8 M | 5.88 M | -52.2 M | -41.5 M | -58.8 M | -77.6 M | -75.9 M | -23.4 M | - | - | - | - |
Depreciation & Amortization |
1.24 M | 998 K | 1.16 M | 706 K | 683 K | 594 K | 465 K | 941 K | 1.44 M | 2.36 M | 2.59 M | 2.43 M | 1.96 M |
Accounts Payables |
7.14 M | 22.5 M | 3.8 M | 3.71 M | 4.15 M | 6.39 M | 2.64 M | 5.56 M | 2.76 M | 1.61 M | 3.9 M | 1.7 M | 1.56 M |
Accounts Receivables |
30.6 M | 40.3 M | 15.5 M | 16 M | 10.1 M | 4.08 M | - | - | 203 K | 5.75 M | 5.75 M | - | - |
Total Inventories |
5.52 M | 9.12 M | 6.62 M | 1.64 M | 1.35 M | 894 K | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Rigel Pharmaceuticals
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | -5.01 M | - | - | -4.07 M | - | -51.8 M | - | -25.6 M | - | 25 M | - | -20 M | - | -36.6 M | -17.1 M | -3.09 M | - | -31.9 M | -17.2 M | -569 K | - | -70.5 M | -50.4 M | -23.4 M | - | -57.8 M | -40.2 M | -20.8 M | - | -63.4 M | -40.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
600 K | 600 K | 400 K | 300 K | 300 K | 357 K | - | 714 K | - | 237 K | - | 758 K | - | 239 K | - | 500 K | 335 K | 171 K | - | 503 K | 337 K | 164 K | - | 431 K | 272 K | 113 K | - | 352 K | 240 K | 126 K | - | 798 K | 584 K | 324 K | - | 1.1 M | 814 K | 435 K | - | 1.85 M | 1.28 M | 655 K | - | 1.94 M | 1.3 M | 669 K | - | 1.8 M | 1.16 M | 552 K | - | 1.43 M | 923 K | 447 K |
Accounts Payables |
3.82 M | 6.13 M | 9.28 M | 8 M | 5.24 M | 6.3 M | 22.5 M | 2.72 M | - | 4.61 M | 3.8 M | 3.14 M | 1.69 M | 5.1 M | 3.71 M | 3.71 M | 3.71 M | 3.71 M | 4.15 M | 4.15 M | 4.15 M | 4.15 M | 6.39 M | 6.39 M | 6.39 M | 6.39 M | 2.64 M | 2.64 M | 2.64 M | 2.64 M | 5.56 M | 5.56 M | 5.56 M | 5.56 M | 2.76 M | 2.76 M | 2.76 M | 2.76 M | 1.61 M | 1.61 M | 1.61 M | 1.61 M | 3.9 M | 3.9 M | 3.9 M | 3.9 M | 1.7 M | 1.7 M | 1.7 M | 1.7 M | 1.56 M | 1.56 M | 1.56 M | 1.56 M |
Accounts Receivables |
30.6 M | 28.9 M | 27.5 M | 23.5 M | 20.8 M | 29.4 M | 40.3 M | 15.5 M | - | 15.2 M | 15.5 M | 15 M | 17.4 M | 142 M | 16 M | 16 M | 16 M | 16 M | 10.1 M | 10.1 M | 10.1 M | 10.1 M | 4.08 M | 4.08 M | 4.08 M | 4.08 M | - | - | - | - | - | - | 95 K | 195 K | 203 K | 203 K | 203 K | 203 K | 5.75 M | 5.75 M | 5.75 M | 5.75 M | 5.75 M | 5.75 M | 5.75 M | 5.75 M | - | - | - | - | - | - | - | - |
Total Inventories |
4.78 M | 8.06 M | 6.58 M | 6.11 M | 10.8 M | 11.1 M | 9.12 M | 7.12 M | - | 6.76 M | 6.62 M | 7.04 M | 6.83 M | 6.95 M | 1.64 M | 1.64 M | 1.64 M | 1.64 M | 1.35 M | 1.35 M | 1.35 M | 1.35 M | 894 K | 894 K | 894 K | 894 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency